The S&P 500′s 10 Best Stocks So Far in 2013

Stocks are bouncing back from last year's underperformance

      View All  
The S&P 500′s 10 Best Stocks So Far in 2013

Boston Scientific

Boston Scientific 185 The S&P 500's 10 Best Stocks So Far in 2013YTD Return: +62%

Boston Scientific (BSX) sells medical devices, traditionally implantable heart disease treatments like defibrillators and pacemakers. With Baby Boomers aging and the big problem of chronic heart disease, this is a great segment to be in. Favorable news about new products in the pipeline has many investors bullish about future earnings, and shares have been bid up handsomely as a result.

Of course, there are risks. Some products are not on the U.S. market yet and FDA approval is not always as easy a task as companies hope. Also, like many companies, Boston Scientific has been struggling to grow top-line revenue and has relied on efficiencies and cost-cutting to boost earnings. Still, the potential of healthcare — specifically BSX treatments for heart disease — is hard to argue against in the long term due to the changing demographics of the U.S.


Article printed from InvestorPlace Media, http://investorplace.com/2013/07/the-sp-500s-10-best-stocks-so-far-in-2013/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.